ALBIREO PHARMA INC's ticker is and the CUSIP is 01345P906. A total of 4 filers reported holding ALBIREO PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $79 | -99.8% | 3,700 | +105.6% | 0.00% | – |
| Q3 2022 | $34,000 | +1033.3% | 1,800 | +800.0% | 0.00% | – |
| Q2 2022 | $3,000 | -97.7% | 200 | -95.5% | 0.00% | – |
| Q1 2022 | $131,000 | -50.2% | 4,400 | -61.1% | 0.00% | – |
| Q4 2021 | $263,000 | +1447.1% | 11,300 | +2160.0% | 0.00% | – |
| Q3 2021 | $17,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $17,000 | -91.7% | 500 | +762.1% | 0.00% | – |
| Q1 2021 | $204,000 | +353.3% | 58 | +383.3% | 0.00% | – |
| Q4 2020 | $45,000 | -45.8% | 12 | -52.0% | 0.00% | – |
| Q3 2020 | $83,000 | -91.6% | 25 | -93.3% | 0.00% | -100.0% |
| Q2 2020 | $985,000 | +62.0% | 372 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $608,000 | +502.0% | 372 | +830.0% | 0.00% | – |
| Q4 2019 | $101,000 | +26.2% | 40 | 0.0% | 0.00% | – |
| Q3 2019 | $80,000 | -58.5% | 40 | -33.3% | 0.00% | -100.0% |
| Q1 2019 | $193,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 32,900 | $1,157,000 | 0.72% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 300 | $11,000 | 0.00% |
| SIMPLEX TRADING, LLC | 500 | $17,000 | 0.00% |